Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01882569 · ClinicalTrials.gov registry record
Optimization of Time-of-Flight Mass Cytometry (CyTOF) Analysis for Evaluation of Immune Changes Following Surgery
A clinical trial, sponsored by Martin Angst.
- Completed
- Registry status
- 5
- Enrollment target
NCT01882569: Completed study, sponsored by Martin Angst.
NCT01882569 is a clinical trial that has completed, run by Martin Angst. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01882569 has completed, sponsored by Martin Angst.
- COMPLETED
- Registry status
- 5 participants
- Enrollment target
Study Summary
Surgical trauma triggers a massive inflammatory response. Over time, both the innate and adaptive branches of the immune system are affected by surgical trauma. The purpose of this study is to use a single cell flow cytometry approach to characterize the cellular and molecular mechanisms involved in the inflammatory response to surgical trauma.
Primary Outcome
This is an exploratory study.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2012-05 |
| Est. Completion | 2014-09 |
What the finished NCT01882569 record still lists
NCT01882569 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 5 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01882569 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01882569 about?
NCT01882569 is a clinical study titled "Optimization of Time-of-Flight Mass Cytometry (CyTOF) Analysis for Evaluation of Immune Changes Following Surgery". Surgical trauma triggers a massive inflammatory response. Over time, both the innate and adaptive branches of the immune system are affected by surgical trauma. The purpose of this study is to use a single cell flow cytometry approach to characterize the cellular and molecular mechanisms involved in...
What is the current status of trial NCT01882569?
This trial is currently completed. The enrollment target is 5 participants. The study started on 2012-05. Estimated completion is 2014-09.
Who is sponsoring clinical trial NCT01882569?
This trial is sponsored by Martin Angst, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia